317 related articles for article (PubMed ID: 21810058)
21. Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report.
Myoken Y; Sugata T; Fujita Y; Fujihara M; Iwato K; Murayama SY; Mikami Y
J Oral Maxillofac Surg; 2006 May; 64(5):860-3. PubMed ID: 16631499
[No Abstract] [Full Text] [Related]
22. Fungal Infections of the Central Nervous System in Children.
McCarthy MW; Kalasauskas D; Petraitis V; Petraitiene R; Walsh TJ
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e123-e133. PubMed ID: 28903523
[TBL] [Abstract][Full Text] [Related]
23. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
24. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
25. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
26. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
[TBL] [Abstract][Full Text] [Related]
27. [Invasive fungal disease due to Scedosporium, Fusarium and mucorales].
Pemán J; Salavert M
Rev Iberoam Micol; 2014; 31(4):242-8. PubMed ID: 25442383
[TBL] [Abstract][Full Text] [Related]
28. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies.
Jensen HE; Salonen J; Ekfors TO
J Pathol; 1997 Jan; 181(1):100-5. PubMed ID: 9072010
[TBL] [Abstract][Full Text] [Related]
29. Diabetes and mucormycosis: a complex interplay.
Rammaert B; Lanternier F; Poirée S; Kania R; Lortholary O
Diabetes Metab; 2012 Jun; 38(3):193-204. PubMed ID: 22386924
[TBL] [Abstract][Full Text] [Related]
30. Invasive fungal sinusitis in the pediatric population: Systematic review with quantitative synthesis of the literature.
Smith A; Thimmappa V; Shepherd B; Ray M; Sheyn A; Thompson J
Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():231-235. PubMed ID: 27729140
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and clinical manifestations of mucormycosis.
Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
[TBL] [Abstract][Full Text] [Related]
32. [Invasive aspergillosis in hematological patients].
Rask CU; Peterslund NA
Ugeskr Laeger; 2000 Feb; 162(6):773-7. PubMed ID: 10689950
[TBL] [Abstract][Full Text] [Related]
33. Opportunistic fungal infections in the critically ill.
Shelton BK
Crit Care Nurs Clin North Am; 2000 Sep; 12(3):323-40. PubMed ID: 11855237
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of pulmonary mucormycosis in two pediatric hematopoietic stem cell transplant patients.
Elgarten CW; Levy EM; Mattei P; Fisher BT; Olson TS; Freedman JL
Pediatr Transplant; 2018 Nov; 22(7):e13270. PubMed ID: 30014584
[TBL] [Abstract][Full Text] [Related]
35. Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.
Ricna D; Lengerova M; Palackova M; Hadrabova M; Kocmanova I; Weinbergerova B; Pavlovsky Z; Volfova P; Bouchnerova J; Mayer J; Racil Z
Mycoses; 2016 Jan; 59(1):48-55. PubMed ID: 26661324
[TBL] [Abstract][Full Text] [Related]
36. Mucormycosis-associated fungal infections in patients with haematologic malignancies.
Kara IO; Tasova Y; Uguz A; Sahin B
Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481
[TBL] [Abstract][Full Text] [Related]
37. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
38. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
39. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
Rogers TR; Slavin MA; Donnelly JP
Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
[TBL] [Abstract][Full Text] [Related]
40. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review.
Hilal AA; Taj-Aldeen SJ; Mirghani AH
Ear Nose Throat J; 2004 Aug; 83(8):556, 558-60, 562. PubMed ID: 15487636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
